On February 27th, 2015 the national newspaper Corriere della Sera has published on its special section “Corriere Sociale,” dedicated to volunteering and Third Sector, an article on CVBF and its activities in the field of rare diseases and paediatrics.
The page describes the four main focus areas of the Consortium: Clinical Trials (promotion of an ethical use of medication, ethics and regulatory counselling, organization and conduction of clinical trials, pharmacovigilance services, CRO and CME providers activities and drug management), Regulatory Consultancy (whose value lies in the set of competencies guaranteed by the consortium members, including Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus), Scientific Research (in particular paediatric clinical research, conducted in the context of European projects), Training (with a special focus on the DEEP project and how it significantly contributes to the paediatric research, by aiming to make available a new formulation of the iron chelator deferiprone – DFP, specifically tested for children of any age, affected by β-thalassaemia major and other transfusion dependent haemoglobinopathies).
Here you can download the complete article
